Status:
COMPLETED
Leveraging Electronic Health Record Data in a Risk Prediction Model to Increase HIV PrEP Intake in Primary Care
Lead Sponsor:
Kaiser Permanente
Conditions:
Pre-Exposure Prophylaxis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Kaiser Permanente Northern California (KPNC) has been a national leader in implementation of HIV preexposure prophylaxis (PrEP), a daily antiretroviral pill that is more than 99% effective in preventi...
Detailed Description
Study Design This is a randomized controlled trial among PCPs at KPSF to evaluate the feasibility of implementing a decision support intervention for PrEP and its impact on PrEP referrals and uptake a...
Eligibility Criteria
Inclusion
- Primary care provider at Kaiser Permanente San Francisco Medical Center
- Provide primary care to adult patients
- more than 150 people without HIV on their primary care physician panel.
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT05991869
Start Date
June 1 2021
End Date
October 31 2022
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northern California Division of Research
Oakland, California, United States, 94612